5-Aza-CdR |
5-aza-2’-deoxycitidine |
HD |
Huntington’s disease |
5-Aza-CR |
5-Azacytidine |
HDAC |
Histone deacetylase |
5caC |
5-carboxylcytosine |
HDACi |
Histone deacetylases inhibitor |
5fC |
5-formylcytosine |
HTT |
Huntingtin |
5hmC |
5-hydroxylcytosine |
KDM5D |
Lys (K)-specific demethylase 5D |
5mC |
5-methycytosine |
KDM5D |
Lys-specific demethylase 5D |
A2AR |
A2A receptor |
L-DOPA |
3, 4-dihydroxy-l-phenylalanine |
AD |
Alzheimer’s disease |
MAPT |
Microtubule-associated protein Tau |
ADD |
ATRX-DNMT3-DNMT3L domain |
MAPT |
Microtubule-associated protein Tau |
Aβ |
Amyloid-beta peptide |
MFG |
Middle frontal gyrus |
AβPP |
Amyloid-β protein precursor |
MPTP |
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
BER |
Base excision repair |
MTG |
Middle temporal gyrus |
CNS |
Central nervous system |
NPC |
Neural progenitor cell |
DhMR |
Differentially hydroxymethylated region |
OL |
Oligodendrocyte |
DNMT |
DNA methyltransferase |
OPC |
Oligodendrocyte progenitor cell |
UHRF1 |
Ubiquitin-like, containing PHD and RING finger domain |
PD |
Parkinson’s disease |
DNMTi |
DNA methyltransferases inhibitor |
polyQ |
Polyglutamine |
ELVOL2 |
ELOVL Fatty Acid Elongase 2 |
PSEN1 |
Presenilin1 |
EOPD |
Early-onset Parkinson’s disease |
SAM |
S-adenosylmethionine |
ESC |
Embryonic stem cell |
SNCA |
α-synuclein |
EWAS |
Epigenome-wide association study |
SNCB |
β-synuclein |
FDA |
Food and Drug Administration |
TBRS |
Tatton-Brown-Rahman syndrome |
GC |
Granule cells |
TDG |
Thymine DNA glycosylase |
H3K4me |
Histone H3K4 methylation |
TET |
Ten-eleven translocation dioxygenase |
H3K4me3 |
Trimethylation of histone H3K4 |
TNF-α |
Tumor necrosis factor α |
H3K9me |
Histone H3K9 methylation |
YAC128 |
128 CAG repeats |